General MedicationsORALStandard
CYTOXAN
CYCLOPHOSPHAMIDE
Standard Dose
50MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary
Approval overview CYTOXAN is listed in Drugs@FDA under application 012141 (NDA).
Review priority: N/A Marketing status: Prescription Active ingredient CYCLOPHOSPHAMIDE Form and strength TABLET;ORAL - 50MG Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2020-08-07 00:00:00.
Structured Monograph
Clinical summary
Approval overview CYTOXAN is listed in Drugs@FDA under application 012141 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient CYCLOPHOSPHAMIDE Form and strength TABLET;ORAL - 50MG Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2020-08-07 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: N/A
Interaction Notes
- No interaction notes stored yet.